Results 171 to 180 of about 182,433 (270)

Pegylated Interferon Alfa [PDF]

, 2020
openaire   +1 more source

Adjuvant pegylated interferon-alpha after nucleos(t)ide analog withdrawal drives a temporally coordinated expansion of regulatory B cells and contraction of HBV-specific T cells

SA Phillips, Alice R. Burton, Helen Cooksley, Jessica E. Davies, Nicola Harris, Dhruti Devshi, Dimple Zope, Niyati Raj, Kornelija Suveizdytė, Emanuela Falaschetti, Hanna Box, Mariam Habib, Eleni Nastouli, Patrick T.F. Kennedy, Kaushik Agarwal, Jack Message, Mark R. Thursz, Shilpa Chokshi, Mala K. Maini, on behalf of the NUC-B Study Group   +19 more
openalex   +1 more source

Effects of tenofovir alafenamide combined with pegylated interferon on clinical symptoms and renal function indicators in patients with chronic hepatitis B.

Juju Liu, Qi Chen, Jie Pan
openalex   +2 more sources

PB3569 Pharmacokinetics, Safety, and Efficacy of Different Doses of Pegylated Interferon Alpha-2b in Hydroxyurea-Resistant or Intolerant Essential Thrombocythemia: A Multicenter, Randomized, Open-Label Phase II Study

Rong Fu, Tong Hongyan, Jian Huang, 段明辉, Tiejun Gong, Yong Wu, Na Xu, Wen Wu, Hu Zhou, Hongxia Shi, Ting Sun, Yalin Yin, Ruoyi He, Ying Zheng, Jianbo Gu, Lei Zhang   +15 more
openalex   +1 more source

Hepatitis B surface antigen clearance rate with pegylated interferon-α therapy in different chronic hepatitis B virus infection populations: A systematic review and meta-analysis

Chengrun Song, Yalin Yin, Jingwen Feng, Yujing Li, Min He, Yonghong Wang, Menglan Wang, Yachao Tao, Taoyou Zhou, Fang He, Jiajie Lu, Wei Jiang, Dongbo Wu, Hong Tang, Xuezhong Lei, Enqiang Chen   +15 more
openalex   +1 more source

From virological selection to immune stratification: Hepatitis B virus-specific T cells for precision pegylated interferon therapy in chronic hepatitis B

Bing Tian, Chen Tian, Chuan-Lai Shen, Qun Zhang   +3 more
openalex   +2 more sources

Nucleos(t)ide withdrawal versus nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B trial)

Mark R. Thursz, Maud Lemoine, Ashley Brown, Ivana Carey, Jack Message, Patrick T.F. Kennedy, Daniel M. Forton, Martin J Wiselka, Mark A. Aldersley, Martin I. Prince, Stuart McPherson, SA Phillips, Shilpa Chokshi, Alice R. Burton, Mala K. Maini, Johannes C. Botha, Eleni Nastouli, Samantha Tsao, Emanuela Falaschetti, Hanna Box, Mariam Habib, Kaushik Agarwal, the NUC-B Study Group   +22 more
openalex   +1 more source

Statins enhance the efficacy of pegylated interferon-alfa2 in Philadelphia-negative chronic myeloproliferative neoplasms. [PDF]

Blood Adv
Davidsen ID, Larsen MK, Löffler L, Skov V, Kjær L, Knudsen TA, Sørensen AL, Christensen SF, Cordua S, Eickhardt-Dalbøge CS, Kristiansen MH, Ellervik C, Wienecke T, Hasselbalch HC.   +13 more
europepmc   +1 more source

Pegylated Interferon Associated Thyroidal Dysfunction Among Hepatitis C Patients

Background: Chronic hepatitis C and interferon both have their effect on thyroid gland function including clinical and subclinical thyroidal dysfunction (TD) that form major clinical manifestations of chronic hepatitis c.
Nida Sajid, Muhammad Imran, Karim Kammeruddin   +2 more
core  

Long-acting pegylated interferon gamma sensitizes AML cells to killing by donor T cells

Vaishali Basu, Gregory Mannino, Laura Mpofu, Heidi Struthers, Sharon J. Carlson, George N. Cox, David H. Spencer, Michael P. Rettig, Matthew J Christopher   +8 more
openalex   +1 more source